p16INK4a Translation Suppressed by miR-24
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Expression of the tumor suppressor p16(INK4a) increases during aging and replicative senescence. METHODOLOGY/PRINCIPAL FINDINGS: Here, we report that the microRNA miR-24 suppresses p16 expression in human diploid fibroblasts and cervical carcinoma cells. Increased p16 expression with replicative senescence was associated with decreased levels of miR-24, a microRNA that was predicted to associate with the p16 mRNA coding and 3'-untranslated regions. Ectopic miR-24 overexpression reduced p16 protein but not p16 mRNA levels. Conversely, introduction of antisense (AS)-miR-24 blocked miR-24 expression and markedly enhanced p16 protein levels, p16 translation, and the production of EGFP-p16 reporter bearing the miR-24 target recognition sites. CONCLUSIONS/SIGNIFICANCE: Together, our results suggest that miR-24 represses the initiation and elongation phases of p16 translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Lowering miR-24 increases p16 levels in HeLa cells. (A) Cells were transfected with either a control (Ctrl.) siRNA or antisense (AS) miR-24 (100 nM) and the levels of mRNAs encoding p16, and controls GAPDH (for normalization) and SDHA were calculated by RT-qPCR and represented as the means+SD from 3 independent experiments; the levels of miR-24 and U6 RNA were also measured. (B) Representative Western blot analysis of p16 (and loading control α-Tubulin) levels in each transfection group. p16 signals were measured by densitometry and represented as % p16 levels relative to the control transfection group. (C) The levels of miR-24 were measured by RT-qPCR in each of the fractions (Materials and Methods) and shown as relative miR-24 levels in the AS-miR-24 transfection group relative to the levels in the Ctrl. siRNA transfection group (left) and also as a percentage of the total miR-24 in each of the two transfection groups (right). Note that the abundance of miR-24 was preferentially reduced in fractions 1 and 2 (left), but the remaining miR-24 was found distributed among all of the fractions of the polysome gradient (right). Data are representative from three independent experiments yielding similar results. (D) The levels of p16 and control GAPDH mRNAs on polysome gradients were measured and represented as explained in the legend of Fig. 1C. (E) Nascent translation of p16 or (control) GAPDH was monitored following incubation of cells with L-[35S]methionine and L-[35S]cysteine for 15 min; after immunoprecipitation (IP) using either anti-p16 (left) or anti-GAPDH (right) antibodies along with control IgG, the incorporation of radiolabeled amino acids into newly synthesized p16 and GAPDH polypeptides was visualized after SDS-PAGE and quantified using a PhosphorImager; the % change in p16 nascent translation is shown.](https://figures.cochat.ai/paper-figures/880eb3a1463b4866ba4e9e44241dd770/p16ink4a-translation-suppressed-by-mir-24-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, miR-24 suppresses p16 INK4a in cells (Lal et al., 2008) and disease models, including osteoarthritis (Philipot et al., 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Lal et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“Multiple studies have demonstrated that different miRNAs modulate the levels of key senescence effectors such as p53 (Hu et al., 2010; Burns et al., 2011; Xiao et al., 2011), p21WAF1/CIP1 (Borgdorff et al., 2010), p16INK4A (Lal et al., 2008; Overhoff et al., 2014; Philipot et al., 2014), and SIRT1 (Suh, 2018; Baker et al., 2019; Barnes et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Lal et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186 · cited 1×
“Transcriptionally, CDC6 was reported to silence the INK4a/ARF locus by heterochromatinization linked to DNA replication [11].”
RetractedThe limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876 · cited 1×
“Cellular senescence is triggered by stimuli such as aberrant proliferative signals or damage to DNA or other macromolecules [4, 5].”
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Miranda, K. C., Huynh, T., Tay, Y., Ang, Y.-S., Tam, W.-L., Thomson, A. M., Lim, B., & Rigoutsos, I. (2006) · Cell · doi:10.1016/j.cell.2006.07.031 · Cited by 2,063 · cited 1×
“), based on analysis using the Miranda and RNA22 programs (”
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060 · cited 6×
“The miRNAmediated silencing of gene expression has been linked to the recruitment of target mRNAs to P-bodies; these foci are implicated in mRNA degradation [31], and also in translational repression as they lack translational constituents and contain protein components of RISC (such as Ago1) that interact directly wi…”
InfluentialMicroRNA-Directed Cleavage of HOXB8 mRNA
Yekta, S., Shih, I.-H., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1097434 · Cited by 1,702
A microRNA in a Multiple-Turnover RNAi Enzyme Complex
Hutvágner, G., & Zamore, P. D. (2002) · Science · doi:10.1126/science.1073827 · Cited by 1,674
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Decapping and Decay of Messenger RNA Occur in Cytoplasmic Processing Bodies
Sheth, U., & Parker, R. (2003) · Science · doi:10.1126/science.1082320 · Cited by 1,365 · cited 1×
“The miRNAmediated silencing of gene expression has been linked to the recruitment of target mRNAs to P-bodies; these foci are implicated in mRNA degradation [31], and also in translational repression as they lack translational constituents and contain protein components of RISC (such as Ago1) that interact directly wi…”
Olsen, P. H., & Ambros, V. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9523 · Cited by 1,234 · cited 1×
“elegans miRNA lin-4, which silenced lin-14 and lin-28 mRNAs without changing their polysomal distribution [34,35].”
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
The role of MicroRNAs in human cancer
Peng, Y., & Croce, C. M. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.4 · Cited by 2,483
Argonaute HITS-CLIP decodes microRNA–mRNA interaction maps
Chi, S. W., Zang, J. B., Mele, A., & Darnell, R. B. (2009) · Nature · doi:10.1038/nature08170 · Cited by 1,791
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
“Many miRNAs expressed in the plasma microvesicles also regulate the progression of the cell cycle proteins [55,56].”
BackgroundMicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Tay, Y., Zhang, J., Thomson, A. M., Lim, B., & Rigoutsos, I. (2008) · Nature · doi:10.1038/nature07299 · Cited by 1,385
Jansson, M. D., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,099
“…the key inducers of senescence p16 and p19, products of the INK4A locus often mutated in cancers (Lee and Dutta, 2007; Nishino et al., 2008; Sherr, 1996). p16 is a specific inhibitor of CDK4/6 and is also repressed by miR24, which is down-regulated during replicative senescence (Lal et al., 2008).”
BackgroundNon‐coding RNAs: regulators of disease
Taft, R. J., Pang, K. C., Mercer, T. R., Dinger, M., & Mattick, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2638 · Cited by 1,058
“However, let-7 also targets the Dicer coding sequence (CDS) [87] (Figure 3b), consistent with what appears to be an emerging theme of noncanonical miRNA targets in developmentally regulated genes [88–92].”
Backgroundp53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2584 · Cited by 665
“The recent finding that microRNAs (miRNAs) can inhibit translation by targeting the coding sequences of genes invites speculation that there are as yet undiscovered miRNAs that can target p53 in a similar fashion, which might explain how silent TP53 polymorphisms in the coding region of the gene could influence p53 ac…”
BackgroundRevisiting the principles of microRNA target recognition and mode of action
Brodersen, P., & Voinnet, O. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2619 · Cited by 658
“Accordingly, two recent studies in human cells have identified functional miRNA target sites in the ORFs of DNA methyltransferase 3b ( DNMT3B ) and of the cell-cycle inhibitor p16 INK4A (also known as CDKN2A”
BackgroundLal, A., Navarro, F., Maher, C. A., Maliszewski, L. E., Yan, N., O'Day, E., Chowdhury, D., Dykxhoorn, D. M., Tsai, P., Hofmann, O., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.020 · Cited by 580
“In addition to seedless 30UTR MREs, we previously identified a coding region miR-24 MRE in p16INK4A (Lal et al., 2008).”
BackgroundInfluentialSelf-citationHuR recruits let-7/RISC to repress c-Myc expression
Kim, H. H., Kuwano, Y., Srikantan, S., Lee, E. K., Martindale, J. L., & Gorospe, M. (2009) · Genes & Development · doi:10.1101/gad.1812509 · Cited by 543
“(AS)let-7b and (AS)let-7c, or with chemically synthesized duplex (Pre)RNAs (Pre)let-7b and (Pre)let-7c (Ambion); RNAs (at 10 nM final) were transfected using Oligofectamine (Kim et al. 2008; Lal et al. 2008).”
MethodSelf-citationDesperately seeking microRNA targets
Thomas, M., Lieberman, J., & Lal, A. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1921 · Cited by 479
“These results support recent findings that miRNAs regulate many genes by 'seedless' or CDS interaction”
ResultSelf-citationMicroRNAs: Novel regulators in the hallmarks of human cancer
Ruan, K., Fang, X., & Ouyang, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.031 · Cited by 447
MicroRNAs and their target gene networks in breast cancer
O'Day, E., & Lal, A. (2010) · Breast Cancer Research · doi:10.1186/bcr2484 · Cited by 439
Self-citationBueno, M. J., & Malumbres, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.002 · Cited by 410
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression
Cunnington, M. S., Santibanez Koref, M., Mayosi, B. M., Burn, J., & Keavney, B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000899 · Cited by 379
“The fact that the results of eQTL and aeQTL mapping were so similar in our study suggests that the effect of regulation at the posttranscriptional level is limited, although regulation of CDKN2A expression by a microRNA has been described [55].”
BackgroundAging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Lee, E. K., Lee, M. J., Abdelmohsen, K., Kim, W., Kim, M. M., Srikantan, S., Martindale, J. L., Hutchison, E. R., Kim, H. H., Marasa, B. S., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00894-10 · Cited by 360
“Indeed, most sites of microRNA-mediated regulation are thought to reside in the 3 -UTR of the mRNA (7), although a few examples of microRNAs regulating gene expression through the coding region of target mRNAs are beginning to emerge (miR-24, miR-519, and miR-148) (6, 7, 23, 24).”
BackgroundSelf-citationmicroRNA Expression Patterns Reveal Differential Expression of Target Genes with Age
Noren Hooten, N., Abdelmohsen, K., Gorospe, M., Ejiogu, N., Zonderman, A. B., & Evans, M. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010724 · Cited by 357
“Intriguingly, it has been shown that miR-24 can target E2F2, p16, MKK4 and H2AX [17,19,29,32].”
BackgroundSelf-citationmiR‐17, miR‐19b, miR‐20a, and miR‐106a are down‐regulated in human aging
Hackl, M., Brunner, S., Fortschegger, K., Schreiner, C., Micutkova, L., Mück, C., Laschober, G. T., Lepperdinger, G., Sampson, N., Berger, P., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00549.x · Cited by 355
“However, other reports on differential expression of miRNAs in replicative senescence of fibroblasts (Brosh et al., 2008; Lal et al., 2008; Bhaumik et al., 2009; Maes et al., 2009), in senes- cence of mesenchymal stem cells (Wagner et al., 2008), of human and mouse brain tissue (Lukiw, 2007; Li et…”
BackgroundControl of cell proliferation pathways by microRNAs
Bueno, M. J., de Castro, I. P., & Malumbres, M. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6833 · Cited by 345
Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to Cancer
Li, J., Poi, M. J., & Tsai, M.-D. (2011) · Biochemistry · doi:10.1021/bi200642e · Cited by 334
MicroRNA and cancer – focus on apoptosis
Wang, Y., & Lee, C. G. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00510.x · Cited by 330
“It is also worth noting that miR-105, miR-144, miR-193 and miR-199b are seldom reported to be deregulated in cancer, despite their relatively early discovery, suggesting that these miRs probably play a role in cellular 14 © 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blac…”
miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes
Qian, L., Van Laake, L. W., Huang, Y., Liu, S., Wendland, M. F., & Srivastava, D. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101547 · Cited by 322
“In addition, miR-24 appears to affect the tumor suppressor p16 (Lal et al., 2008), the DNA repair process, and cell cycle regulation (Lal et al., 2009a,b; Rogler et al., 2009).”
BackgroundChhabra, R., Dubey, R., & Saini, N. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-232 · Cited by 324
“Previous study by Lal et al further strengthened the proliferative function of miR24 where they have shown that miR-24 directly suppresses CDK inhibitor p16INK4A which arrests cells in the G1 phase [77].”
BackgroundDysregulation of microRNAs in cancer: Playing with fire
Melo, S. A., & Esteller, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.08.009 · Cited by 315
“is controlled by miR-24, a miRNA that is down-regulated during replicative senescence [179].”
BackgroundThe Molecular Balancing Act of p16INK4a in Cancer and Aging
LaPak, K. M., & Burd, C. E. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0350 · Cited by 291
Senile Osteoporosis: The Involvement of Differentiation and Senescence of Bone Marrow Stromal Cells
Qadir, A., Liang, S., Wu, Z., Chen, Z., Hu, L., & Qian, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21010349 · Cited by 268
Galgano, A., Forrer, M., Jaskiewicz, L., Kanitz, A., Zavolan, M., & Gerber, A. P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003164 · Cited by 270
“On the other hand, microRNAs (miRNAs), ,22 nucleotide (nt) long RNA molecules, can repress gene expression by basepairing with sequences in 39-untranslated regions (39-UTRs) of messages and thus inhibit their translation or promote decay [8,9].”
BackgroundInteractive exploration of RNA22 microRNA target predictions
Loher, P., & Rigoutsos, I. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts615 · Cited by 264
“RNA22 has successfully predicted non-canonical targets as well as targets beyond the 3 0 -untranslated region (3 0 -UTR) (Duursma et al. , 2008; Lal et al. , 2008, 2009; Tay et al. , 2008).”
BackgroundmiR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells
Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J., & Jin, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009429 · Cited by 247
“encoding the tumor suppressor p16 (INK4a) [35].”
The complexities of microRNA regulation: mirandering around the rules
Breving, K., & Esquela-Kerscher, A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.09.016 · Cited by 244
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Muller, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 238
Rigoutsos, I. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0352 · Cited by 235
“In the article by Lal and colleagues (28), the authors show that miR-24 suppresses p16 expression in human diploid fibroblasts and”
BackgroundAging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis
Drummond, M. J., McCarthy, J. J., Sinha, M., Spratt, H. M., Volpi, E., Esser, K. A., & Rasmussen, B. B. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00148.2010 · Cited by 235
“Other reports indicate altered miRNA expression patterns in aging human cells (1, 19, 30, 33, 39) that potentially regulate cellular pathways involved in inflammation (1) and stress (33).”
Asl, E. R., Amini, M., Najafi, S., Mansoori, B., Mokhtarzadeh, A., Mohammadi, A., Lotfinejad, P., Bagheri, M., Shirjang, S., Lotfi, Z., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119499 · Cited by 231
miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels
Abdelmohsen, K., Srikantan, S., Kuwano, Y., & Gorospe, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809376106 · Cited by 230
Self-citationPhilipot, D., Guérit, D., Platano, D., Chuchana, P., Olivotto, E., Espinoza, F., Dorandeu, A., Pers, Y.-M., Piette, J., Borzi, R. M., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4494 · Cited by 226
“We found miR-24, a known negative regulator of p16, through the presence of two binding sites for this miR within its encoding and 3′ untranslated region (UTR) [51].”
Senescence-associated lncRNAs: senescence-associated long noncoding RNAs
Abdelmohsen, K., Panda, A., Kang, M.-J., Xu, J., Selimyan, R., Yoon, J.-H., Martindale, J. L., De, S., Wood, W. H., Becker, K. G., et al. (2013) · Aging Cell · doi:10.1111/acel.12115 · Cited by 208
“The second comprises miRNAs, a large group of small (~22 nt), noncoding RNAs that are differentially expressed during senescence and control numerous senescence traits in cultured cells as well as in animal models (Lal et al., 2008; Maes et al., 2009; Marasa et al., 2010; Bonifacio & Jarstfer, 2010; Wang et al., 2011;…”
BackgroundSelf-citationCRD-BP Protects the Coding Region of βTrCP1 mRNA from miR-183-Mediated Degradation
Elcheva, I., Goswami, S., Noubissi, F. K., & Spiegelman, V. S. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.007 · Cited by 192
“, 2005), and with the recent data that miRNAs might target the coding regions of several mRNAs and downregulate the gene expression predominantly through inhibition of translation (Duursma et al., 2008; Forman et al., 2008; Lal et al., 2008; Tay et al., 2008).”
Moretti, F., Thermann, R., & Hentze, M. W. (2010) · RNA · doi:10.1261/rna.2384610 · Cited by 166
“…effective miR-binding sites have also been identified in the 59UTR or the open reading frame (ORF) of target mRNAs (e.g., Jopling et al. 2005; Duursma et al. 2008; Forman et al. 2008; Henke et al. 2008; Lal et al. 2008; Ørom et al. 2008; Tay et al. 2008; Elcheva et al. 2009; Tsai et al. 2009).”
BackgroundmiR-24 up-regulation in oral carcinoma: Positive association from clinical and in vitro analysis
Lin, S.-C., Liu, C.-J., Lin, J.-A., Chiang, W.-F., Hung, P.-S., & Chang, K.-W. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2009.12.005 · Cited by 160
Zhang, X., Liu, Z., Yi, J., Tang, H., Xing, J., Yu, M., Tong, T., Shang, Y., Gorospe, M., & Wang, W. (2012) · Nature Communications · doi:10.1038/ncomms1692 · Cited by 167
“Moreover, although miR-24 was described as a repressor for p16 translatio”
BackgroundSelf-citationThe code within the code: microRNAs target coding regions
Forman, J. J., & Coller, H. A. (2010) · Cell Cycle · doi:10.4161/cc.9.8.11202 · Cited by 154
“Increased p16 expression with replicative senescence was associated with decreased miR-24 expression, and miR-24 was found to repress p16 expression primarily through a coding region recognition site.(27) Finally, five functional coding region target sites for the miR-296, miR-470 and miR-134 microRNAs were discovered…”
BackgroundTakagi, S., Nakajima, M., Kida, K., Yamaura, Y., Fukami, T., & Yokoi, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085431 · Cited by 151
The role of exosomes and microRNAs in senescence and aging
Xu, D., & Tahara, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.010 · Cited by 162
Oncogenic MicroRNAs: Key Players in Malignant Transformation
Frixa, T., Donzelli, S., & Blandino, G. (2015) · Cancers · doi:10.3390/cancers7040904 · Cited by 147
“It has been demonstrated that different oncogenic miRNAs have cell cycle inhibitors of the INK4 or Cip/Kip families as targets, determining an aberrant DNA damage response [37–43].”
BackgroundDu, W. W., Fang, L., Li, M., Yang, X., Liang, Y.-Y., Peng, C., Wei, Q., O’Malley, Y., Askeland, R. W., Sugg, S. L., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.118299 · Cited by 157
Self-citationMiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells
Zhou, H., & Rigoutsos, I. (2014) · RNA · doi:10.1261/rna.045757.114 · Cited by 136
“…shown that miRNAs can also target mRNAs within their CDS and decrease the corresponding protein’s abundance (Duursma et al. 2008; Forman et al. 2008; Lal et al. 2008; Shen et al. 2008; Tay et al. 2008; Rigoutsos 2009; Brest et al. 2011; Hao et al. 2011; Nelson et al. 2011; Sauna and Kimchi-Sarfaty…”
BackgroundEpstein–Barr virus growth/latency III program alters cellular microRNA expression
Cameron, J. E., Fewell, C., Yin, Q., McBride, J., Wang, X., Lin, Z., & Flemington, E. K. (2008) · Virology · doi:10.1016/j.virol.2008.09.018 · Cited by 135
“For instance, miR-24 has been demonstrated to promote cell growth through repression of p16INK4a, consistent with the growth phenotype of cells expressing EBV latency III transcripts (Lal et al., 2008).”
BackgroundAberration of blastocyst microRNA expression is associated with human infertility
McCallie, B. R., Schoolcraft, W. B., & Katz‐Jaffe, M. G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.069 · Cited by 143
MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence
Marasa, B. S., Srikantan, S., Martindale, J. L., Kim, M. M., Lee, E. K., Gorospe, M., & Abdelmohsen, K. (2010) · Aging · doi:10.18632/aging.100159 · Cited by 132
Self-citationmiRNAs: Key Players in Neurodegenerative Disorders and Epilepsy
Karnati, H. K., Panigrahi, M. K., Gutti, R. K., Greig, N. H., & Tamargo, I. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150395 · Cited by 124
Lafferty‐Whyte, K., Cairney, C. J., Jamieson, N. B., Oien, K. A., & Keith, W. N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.003 · Cited by 124
Kim, Y. J., Hwang, S. H., Lee, S. Y., Shin, K. K., Cho, H. H., Bae, Y. C., & Jung, J. S. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0429 · Cited by 116
“…associated with decreased levels of miR-24, a miRNA that was predicted to associate with the p16 mRNA coding and 3 ¢ -untranslated regions (UTRs) [16]. miR-15b, miR-24, miR-25, and miR-141 overexpression decreases replicative senescence of WI-38 cells through the inhibition of MKK4 protein…”
The panorama of miRNA-mediated mechanisms in mammalian cells
Stroynowska-Czerwińska, A., Fiszer, A., & Krzyżosiak, W. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1551-6 · Cited by 131
“Until recently, functional miRNA-binding sites were thought to be usually localized within the 3′UTR [129] but might also be present within the coding sequence (CDS) [135–139] and the 5′UTR [140–142].”
A high throughput experimental approach to identify miRNA targets in human cells
Tan, L. P., Seinen, E., Duns, G., de Jong, D., Sibon, O. C. M., Poppema, S., Kroesen, B.-J., Kok, K., & van den Berg, A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp715 · Cited by 115
MiRNA-181a Regulates Adipogenesis by Targeting Tumor Necrosis Factor-α (TNF-α) in the Porcine Model
Li, H., Chen, X., Guan, L.-Z., Qi, Q., Shu, G., Jiang, Q., Li, Y., Xi, Q., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071568 · Cited by 122
“Most miRNAs function by targeting the 3’ UTR of mRNA, although a few miRNAs have been demonstrated to regulate gene expression through the coding region of target mRNAs [8,34].”
BackgroundLet-7b is a novel regulator of hepatitis C virus replication
Cheng, J., Yeh, Y., Tseng, C., Hsu, S., Chang, Y., Sakamoto, N., & Huang, H. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0940-6 · Cited by 122
“For example, miR-148 and miR-24 repress DNA methyltransferase 3b and p16 expression, respectively, primarily through the coding region recognition site [38, 39].”
BackgroundmicroRNA and aging: A novel modulator in regulating the aging network
Chen, L.-H., Chiou, G., Chen, Y., Li, H.-Y., & Chiou, S. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.002 · Cited by 125
Recent trends in targeting miRNAs for cancer therapy
Shah, V., & Shah, J. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13351 · Cited by 125
“The miR-24 is downregulated in replicative senescence.([98]) miR-34a of the miR-34 family regulates p53, acting as an important regulator of senescence by targeting at multiple sites.”
BackgroundCircular reasoning: microRNAs and cell-cycle control
Chivukula, R. R., & Mendell, J. T. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.06.008 · Cited by 111
MicroRegulators come of age in senescence
Gorospe, M., & Abdelmohsen, K. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.005 · Cited by 108
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Although proliferating HDFs expressed high levels of miR-24, leading to low p16 expression, and late-passage (near-senescent) HDFs expressed low miR-24, which allowed p16 expression, ectopic overexpression of miR-24 alone did not preve…”
BackgroundInfluentialSelf-citationClinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer
Rachagani, S., Macha, M. A., Heimann, N., Seshacharyulu, P., Haridas, D., Chugh, S., & Batra, S. K. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.020 · Cited by 110
Novel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage
Grillari, J., & Grillari‐Voglauer, R. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.007 · Cited by 119
“…surprising that differential miRNA transcription has been found in replicative senescence of fibroblasts (Bhaumik et al., 2009; Brosh et al., 2008; Lal et al., 2008; Maes et al., 2009), and human mesenchymal stem cells (Wagner et al., 2008), as well as in human umbilical vein endothelial cells, T…”
Mishra, P. J., Song, B., Mishra, P. J., Wang, Y., Humeniuk, R., Banerjee, D., Merlino, G., Ju, J., & Bertino, J. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008445 · Cited by 105
“MiR-24 also plays a role in erythropoiesis by regulating ALK4 and in replicative senescence by regulating p16 [20,21].”
BackgroundMicroRNA-24 Is a Novel Regulator of Aldosterone and Cortisol Production in the Human Adrenal Cortex
Robertson, S., MacKenzie, S. M., Alvarez‐Madrazo, S., Diver, L. A., Lin, J., Stewart, P. M., Fraser, R., Connell, J., & Davies, E. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01102 · Cited by 118
“such as cell proliferation and cell apoptosis, depending on context.(34,35) The majority of validated targets for miR-24 are related to regulation of the cell cycle,(29) which may explain its”
BackgroundCopy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors
Petrini, I., Meltzer, P. S., Zucali, P. A., Luo, J., Lee, C. R., Santoro, A., Lee, H. S., Killian, K. J., Wang, Y., Tsokos, M., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.92 · Cited by 107
“The loss of p16 expression has been shown to be possibly related to p16 promoter methylation(9,10) or miR-24 deregulation.(11)”
BackgroundMicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells
Xie, Y., Tobin, L. A., Camps, J., Wangsa, D., Yang, J., Rao, M., Witasp, E., Awad, K. S., Yoo, N., Ried, T., et al. (2012) · Oncogene · doi:10.1038/onc.2012.258 · Cited by 104
“miR-24 has also been reported to inhibit erythropoiesis by targeting activin type I receptor ALK4 (21) and suppress the expression of p16 in human diploid fibroblasts and cervical carcinoma cells (22).”
BackgroundArgonaute CLIP-Seq reveals miRNA targetome diversity across tissue types
Clark, P. M., Loher, P., Quann, K., Brody, J., Londin, E. R., & Rigoutsos, I. (2014) · Scientific Reports · doi:10.1038/srep05947 · Cited by 94
MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia
Xu, Y. J., Li, F., Zhang, B., Zhang, K., Zhang, F., Huang, X., Sun, N., Ren, Y., Sui, M., & Liu, P. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1070 · Cited by 105
Tsirigos, A., & Rigoutsos, I. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000610 · Cited by 97
Noncoding RNA control of cellular senescence
Abdelmohsen, K., & Gorospe, M. (2015) · WIREs RNA · doi:10.1002/wrna.1297 · Cited by 90
“Translation of p16 was repressed by miR-24 in human cervical carcinoma cells and diploid fibroblasts.(94) A negative correlation between miR-24 and p16 in senescent cells was reported in osteoarthritis-associated senescence, where miR-24 levels were reduced while p16 levels were elevated,(95) although miR-24 itself ha…”
BackgroundSelf-citationCardiovascular Importance of the MicroRNA‐23/27/24 Family
BANG, C., FIEDLER, J., & THUM, T. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2011.00153.x · Cited by 90
“Previous reports found that miR-24 impaired the initiation and elongation phases during translation of the mRNA encoding the tumor suppressor p16 (INK4) [20].”
BackgroundMIR-23A microRNA cluster inhibits B-cell development
Kong, K. Y., Owens, K. S., Rogers, J. H., Mullenix, J., Velu, C. S., Grimes, H. L., & Dahl, R. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.04.004 · Cited by 89
“As shown in Table 1, validated miR-24 targets include the proapoptotic proteins APAF1 and caspase 9, as well as cell-cycle inhibitor INK4A [29,32–40].”
BackgroundRole of micro RNA s and long‐non‐coding RNA s in CD 4+ T‐cell differentiation
Pagani, M., Rossetti, G., Panzeri, I., de Candia, P., Bonnal, R. J. P., Rossi, R. L., Geginat, J., & Abrignani, S. (2013) · Immunological Reviews · doi:10.1111/imr.12055 · Cited by 109
Exposure to ultrafine particulate matter induces NF-κβ mediated epigenetic modifications
Bhargava, A., Shukla, A., Bunkar, N., Shandilya, R., Lodhi, L., Kumari, R., Gupta, P. K., Rahman, A., Chaudhury, K., Tiwari, R. R., et al. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.05.065 · Cited by 88
MicroRNAs, the DNA damage response and cancer
Wouters, M. D., van Gent, D. C., Hoeijmakers, J. H. J., & Pothof, J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.03.012 · Cited by 102
Senescence-Associated MicroRNAs
Munk, R. B., Panda, A. C., Grammatikakis, I., Gorospe, M., & Abdelmohsen, K. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.008 · Cited by 99
“5.2 Impact on Pathology by SA-MicroRNAs in the p16/RB Pathway MiR-24 inhibits p16 expression (Lal et al., 2008) and promoted cell growth, proliferation, and metastasis in gastric cancer cells, nonsmall cell lung cancer, and breast cancer, although Int Rev Cell Mol Biol.”
BackgroundInfluentialSelf-citationEmerging insights in senescence: pathways from preclinical models to therapeutic innovations
Mansfield, L., Ramponi, V., Gupta, K., Stevenson, T., Mathew, A. B., Barinda, A. J., Herbstein, F., & Morsli, S. (2024) · npj Aging · doi:10.1038/s41514-024-00181-1 · Cited by 88
Aparicio, O., Carnero, E., Abad, X., Razquin, N., Guruceaga, E., Segura, V., & Fortes, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1028 · Cited by 94
Discovering small-molecule senolytics with deep neural networks
Wong, F., Omori, S., Donghia, N. M., Zheng, E. J., & Collins, J. J. (2023) · Nature Aging · doi:10.1038/s43587-023-00415-z · Cited by 82
“Increased p16 and p21 mRNA levels are associated with senescence 35–38 , and decreased mRNA levels of KI67, a proliferation marker, are associated with growth arrest 39,40 .”
BackgroundMicroRNA‐24 targeting RNA‐binding protein DND1 in tongue squamous cell carcinoma
Liu, X., Wang, A., Heidbreder, C. E., Jiang, L., Yu, J., Kolokythas, A., Huang, L., Dai, Y., & Zhou, X. C. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.040 · Cited by 89
“In contrast, ectopic transfection of miR-24 reduced the protein levels of both DND1 and CDKN2A in UM2 cells (Fig.”
BackgroundResultInfluentialMasuda, K., Marasa, B., Martindale, J. L., Halushka, M. K., & Gorospe, M. (2009) · Aging · doi:10.18632/aging.100073 · Cited by 81
“Early-passage, proliferating (‘young’) WI-38 HDFs were cultured until they ceased cell division and became senescent, as previously reported [51].”
BackgroundSelf-citationMicroRNA controls of cellular senescence
Suh, N. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.10.209 · Cited by 78
“increased p16 levels with replicative senescence (70).”
BackgroundMarasa, B. S., Srikantan, S., Masuda, K., Abdelmohsen, K., Kuwano, Y., Yang, X., Martindale, J. L., Rinker-Schaeffer, C. W., & Gorospe, M. (2009) · Science Signaling · doi:10.1126/scisignal.2000442 · Cited by 78
Self-citationKatoh, M. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00061 · Cited by 87
“…2009a), CDC2 (Lal et al., 2009a), CDK4 (Cyclin-dependent kinase 4) (Lal et al., 2009a), CDKN1B (p27 KIP1) (Giglio et al., 2013), CDKN2A (p16 INK4a) (Lal et al., 2008), DHFR (Dihydrofolate reductase) (Mishra et al., 2007), DIAPH1 (Diaphanos homolog 1) (Zhou et al., 2013a), DUSP16 (MKP7) (Zaidi et…”
Lovric, J., Mano, M., Zentilin, L., Eulalio, A., Zacchigna, S., & Giacca, M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.144 · Cited by 77
MicroRNAs -the Next Generation Therapeutic Targets in Human Diseases
Sakthivel, S., Selvan, S. T., Archunan, G., Gulyás, B. Z., & Padmanabhan, P. (2013) · Theranostics · doi:10.7150/thno.7026 · Cited by 79
“MiRNAs are accompanying with the pathogenesis of Parkinson's disease, as found in many other diseases[34, 35].”
BackgroundMicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?
Voorhoeve, P. M. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.09.003 · Cited by 85
Effect of young exosomes injected in aged mice
Lee, B.-R., Kim, J.-H., Choi, E.-S., Cho, J. H., & Kim, E. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s170680 · Cited by 72
Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis
McLoughlin, H. S., Fineberg, S. K., Ghosh, L. L., Tecedor, L., & Davidson, B. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.009 · Cited by 72
“…regulators in many model systems including those studied in cancer (Gillies and Lorimer, 2007; Linsley et al., 2007; Chivukula and Mendell, 2008; Lal et al., 2008; Medina et al., 2008; Xia et al., 2009, 2010), and several have been specifically implicated in regulating cell cycle kinetics…”
BackgroundPre-Micro RNA Signatures Delineate Stages of Endothelial Cell Transformation in Kaposi Sarcoma
O’Hara, A. J., Chugh, P., Wang, L., Netto, E. M., Luz, E., Harrington, W. J., Dezube, B. J., Damania, B., & Dittmer, D. P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000389 · Cited by 79
“Tantalizing data predict p16 and dehydrofolate reductase (DHFR) as mir-24 targets among others [93,94,95,96,97].”
BackgroundMicroRNA regulation associated chondrogenesis of mouse MSCs grown on polyhydroxyalkanoates
Yan, C. Y. I., Wang, Y., Shen, X., Yang, G., Jian, J., Wang, H.-S., Chen, G., & Wu, Q. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.031 · Cited by 73
miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma
Tesfaye, A. A., Azmi, A. S., & Philip, P. A. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.005 · Cited by 72
Genetics and epigenetics of cutaneous malignant melanoma: A concert out of tune
van den Hurk, K., Niessen, H. E. C., Veeck, J., van den Oord, J. J., Steensel, M. A. M. V., Hausen, A. Z., van Engeland, M., & Winnepenninckx, V. J. L. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.011 · Cited by 81
Hatse, S., Brouwers, B., Dalmasso, B., Laenen, A., Kenis, C., Schöffski, P., & Wildiers, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110644 · Cited by 67
“Neither did we find age-related changes in plasma expression of miR-24, which has been shown to suppress the expression of the senescence gene p16 in human diploid fibroblasts [36].”
BackgroundXia, Z., Clark, P., Huynh, T., Loher, P., Zhao, Y., Chen, H.-W., Rigoutsos, I., & Zhou, R. (2012) · Scientific Reports · doi:10.1038/srep00569 · Cited by 71
The transcription factor Slug represses p16Ink4a and regulates murine muscle stem cell aging
Zhu, P., Zhang, C., Gao, Y., Wu, F., Zhou, Y., & Wu, W.-S. (2019) · Nature Communications · doi:10.1038/s41467-019-10479-4 · Cited by 66
Metadata
- Authors
- Lal, A., Kim, H. H., Abdelmohsen, K., Kuwano, Y., Pullmann, R., Srikantan, S., Subrahmanyam, R., Martindale, J. L., Yang, X., Ahmed, F., Navarro, F., Dykxhoorn, D., Lieberman, J., & Gorospe, M.
- Affiliations
- National Institutes of Health (US)
- Harvard University (US)
- Corresponding author
- Lal, Ashish
- Gorospe, Myriam
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-03-26
- Volume
- 3
- Issue
- 3
- Pages
- e1864
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2274865
- OpenAlex
- W2119066197
- Cited by
- 268
- References
- 40
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 13 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 14 · 2018: 9 · 2017: 8 · 2016: 8 · 2015: 14 · 2014: 20 · 2013: 22 · 2012: 26
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- p16INK4a, miR-24, microRNA, translation repression, translational regulation, replicative senescence, aging, tumor suppressor, 3' untranslated region, cervical cancer, human diploid fibroblasts
- MeSH terms
- Base Sequence, HeLa Cells, Humans, Protein Biosynthesis, Mutagenesis, Site-Directed, DNA Primers, Cyclin-Dependent Kinase Inhibitor p16, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.